<?xml version="1.0" encoding="UTF-8"?>
<p>The EV-A71 virus is enclosed by the capsid proteins VP1, VP2, VP3, and VP4 
 <xref rid="B1" ref-type="bibr">
  <sup>1</sup>
 </xref> . VP1 shows the major antigenicity and has been defined as the neutralization determinant 
 <xref rid="B1" ref-type="bibr">
  <sup>1</sup>
 </xref> . Based on VP1 nucleotide sequence analysis, EV-A71 can be divided into three distinct genogroups (e.g., A, B, and C) 
 <xref rid="B1" ref-type="bibr">
  <sup>1</sup>
 </xref>
 <sup>,</sup>
 <xref rid="B25" ref-type="bibr">
  <sup>25</sup>
 </xref> . Genogroup A includes the prototype EV-A71 strain (BrCr-CA-70); this strain was first isolated in 1969 in the USA 
 <xref rid="B14" ref-type="bibr">
  <sup>14</sup>
 </xref> , although it was not identified until 2008, in China 
 <xref rid="B9" ref-type="bibr">
  <sup>9</sup>
 </xref> . Genogroup B can be divided into subgenogroups B1-B5, and genogroup C can be further divided into subgenogroups C1-C5 
 <xref rid="B16" ref-type="bibr">
  <sup>16</sup>
 </xref> . Recently, the C4 genogroup was once more subdivided into the C4a and C4b lineages. Genogroup D was initially identified in India 
 <xref rid="B4" ref-type="bibr">
  <sup>4</sup>
 </xref> , and genogroups E and F were initially identified in Africa 
 <xref rid="B4" ref-type="bibr">
  <sup>4</sup>
 </xref> .
</p>
